De Novo Identification of Expressed Cancer Somatic Mutations from Single-cell RNA Sequencing Data
Overview
Authors
Affiliations
Identifying expressed somatic mutations from single-cell RNA sequencing data de novo is challenging but highly valuable. We propose RESA - Recurrently Expressed SNV Analysis, a computational framework to identify expressed somatic mutations from scRNA-seq data. RESA achieves an average precision of 0.77 on three in silico spike-in datasets. In extensive benchmarking against existing methods using 19 datasets, RESA consistently outperforms them. Furthermore, we applied RESA to analyze intratumor mutational heterogeneity in a melanoma drug resistance dataset. By enabling high precision detection of expressed somatic mutations, RESA substantially enhances the reliability of mutational analysis in scRNA-seq. RESA is available at https://github.com/ShenLab-Genomics/RESA .
Correction: Genome Med 15, 115 & Genome Med 16, 3.
Shen N Genome Med. 2024; 16(1):68.
PMID: 38745249 PMC: 11092180. DOI: 10.1186/s13073-024-01343-2.
De novo detection of somatic variants in high-quality long-read single-cell RNA sequencing data.
Dondi A, Borgsmuller N, Ferreira P, Haas B, Jacob F, Heinzelmann-Schwarz V bioRxiv. 2024; .
PMID: 38496441 PMC: 10942462. DOI: 10.1101/2024.03.06.583775.